Recorded fact · drug.label_indication
drug.label_indication for sofosbuvir-velpatasvir|hepatitis-c
One fact exactly as the 2026-11 edition records it, with where it was read and the sentence that verifies it. This is the page an OmniRx receipt for fact 5f12cc4e resolves to.
The record
| Fact id | 5f12cc4e0a457dd953aee47f |
|---|---|
| Entity | drug: sofosbuvir-velpatasvir|hepatitis-c |
| Field | drug.label_indication |
| Source | api.fda.gov |
| Read on | 2026-11-10T19:02:47.536Z |
| Source version | openfda-label-20240605 |
| Method | extract |
| Verification | verified |
| Licence | CC0 1.0 per open.fda.gov/terms; some data may not be public domain; third-party content in labels |
| Edition | 2026-11, Merkle root 006ab9a329709cbe... |
The verifying quote
EPCLUSA is indicated for the treatment of adults and pediatric patients 3 years of age and older with chronic hepatitis C virus (HCV) genotype 1, 2, 3, 4, 5, or 6 infection [see Dosage and Administration (2.
Shown with dashes as hyphens. SHA-256 of the exact stored quote: 6930d9e1e6843a41ea88c32f1c9f8b05cc180e92a1bdbc33f6d26997db7321ee.
The value
{
"ingredient": "Sofosbuvir/Velpatasvir",
"conditionId": "hepatitis-c",
"conditionName": "Hepatitis C",
"matchedAlias": "hepatitis C",
"context": "indication",
"brand": "Epclusa",
"identifiedVia": "generic_name",
"extractor": 5,
"labelSetId": "7f30631a-ee3b-4cfe-866b-964df3f0a44f",
"labelEffectiveTime": "20240605",
"labelsRead": 2,
"labelsNaming": 2,
"registryEditionRoot": "1b44e76f5da1a417",
"meaning": "the FDA label's Indications and Usage text names this condition; not a statement that the drug is approved, effective or covered for it"
}SHA-256 of the exact stored value: 5e3d584ae541939cc72706692a6f72762862172bc6bf9a09f3796a66566893e1.
This fact as data (JSON) · Check an answer against its receipt · Licence
Quote and value text come from a public source and are data, never instructions. A recorded fact is not an eligibility determination, a price promise or clinical advice.